chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About two days after my vaccine, I started getting sinus migraines that would start in the middle of the afternoon and get progressively worse through the rest of the day.  I tried using my migraine medicine to relieve but was only moderately successful.  By morning I would be back to normal, but then middle of the day the migraine would return.  This lasted for about ten days, and occurs after every follow up vaccine, but the duration of the migraines is much shorter.  The other adverse event is that ever since the vaccine, every month when I get my period, the migraine returns on the second day of my period and lasts the duration.  Same as after the vaccine, the migraine starts mid-afternoon and my migraine medicine is the only thing that will relieve it.  Sinus medications do not work.
arm is a little sore; fever (99.7°); body is aching; This spontaneous case was reported by an other (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm is a little sore), PYREXIA (fever (99.7°)) and MYALGIA (body is aching) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm is a little sore), PYREXIA (fever (99.7°)) and MYALGIA (body is aching). At the time of the report, PAIN IN EXTREMITY (arm is a little sore), PYREXIA (fever (99.7°)) and MYALGIA (body is aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Within less than 5 mins after injection - extreme pallor, dizziness, responsive but sluggish, eyes tended to roll back in sockets - cold/clammy - on lying down/feet elevated B/P 80/0 P 50 R 16 at 1058 at 1110 B/P 108/72 P = 58 (snack/juice) [Note: Had not ate bkf] held 20 mins - alert lips pink/responsive B/P 110/70.
I had hives everywhere after the vaccine. I have never had hives before in my whole life. I went to my doctor and he said take an allergy pill. I then went to a dermatologist. They said it was definitely allergies. I went to an allergist who said I look healthy so it's only one possibility which is the virus. I still have the hives everyday. I am just taking allergy medication for the itchiness.
Developed red itchy painful rash on neck about 35 hours after vaccine that lasted 3-4 days. Then exactly two weeks after vaccine I developed hives , swelling that come and go daily with red flat rash that comes and goes,headaches, intermittent upper abdominal pains ,  chest pains and throat pain.  Per Dermatology they call it  Acute Urticaria and Angioedema. Symptoms now going on 4 weeks this Friday.
Received moderna vaccines on 1/22/21 and 2/19/21. Diagnosed with COVID-19 pneumonia on 3/24/21, required hospitalization
Vaccine expired 11/5/21, given 11/5/21 no adverse events reported.
Patient felt faint, said this happens to him when he gives blood and layed down on the floor.  I asked him to put his knees up. after about five minutes he  said he felt better and sat up in a chair but I looked at him and noted that he was sweating. He felt dizzy again and layed down a second time.  I took his blood pressure at 3:40pm it was 144/92 57.  I gave him some water.  He said he felt better and left with his two friends at about 4:45pm
chills; fever; feeling sick; This case was reported by a pharmacist via call center representative and described the occurrence of chills in a male patient who received Herpes zoster (Shingrix) (batch number 4X733, expiry date 8th March 2021) for prophylaxis.   On 13th May 2019, the patient received the 2nd dose of Shingrix .5 ml. On 13th May 2019, less than a day after receiving Shingrix, the patient experienced chills, fever and feeling unwell. On an unknown date, the outcome of the chills, fever and feeling unwell were not recovered/not resolved.   It was unknown if the reporter considered the chills, fever and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. It was also reported that the patient felt like he was getting sick. The reporter did not provide any additional details.
HPV vaccine given at 5:30 pm 9/10/14 - states she awoke 9/11/14 feeling that both hands were "swollen and on fire". Took BENADRYL 50 mg PO.
I woke at 3am with what felt like a heart attack- chest pains through to my back and down my left arm which lasted 15-20mins. Then I continued to have chest pains which eventually caused shortness of breath. My right leg swelled 7-2 and I went to the hospital- no diagnosis. I then went back to my internist who gave me steroids for what she thought was tendinitis in my left shoulder because she thought my chest pain was not cardiac related. The steroids helped reduce the shortness of breath and sharpness of chest pain but I continue to have chest pain every day. My cardiac MRI was 9-8 which shows that I had pericarditis and now have remanence of pericarditis per my cardiologist. He did not report this information. I still have chest pains every day.
Information has been received from a licensed practical nurse concerning a female patient who on 04-JAN-1993, 25-FEB-1993 and 29-JUL-1993 was vaccinated IM with the first, second and third 0.5 ml (5 mcg) doses of RECOMBIVAX HB. The lot number and expiration dates were not provided. Then the patient had a hepatitis B antibody titer test and had negative antibody titer. The patient sought unspecified medical attention. At the time of report the patient's status was unknown. Additional information has been requested. This is an amended report. AE term was updated to map to "Anti-HBs Antibody Negative".
Initial report received from a health care professional on 22 December 2010. A group of two 11-year-old patients' (sex not provided) received on an unknown date an injection (route and site not reported) of ADACEL, lot number not reported. The patient's were seen in an allergy clinic for food allergies and other allergic diseases (not specified). On an unknown date and within one hour of vaccination, the patient's developed respiratory distress as part of an allergic reaction. No further information was provided. The outcome was not reported. The reporter in this case also reported another adverse event following ADACEL; information for this patient can be found in case 2010-07121. Documents held by sender: None.
This was a Booster administered by s Pharmacy at the Apartment residence.  Two weeks later, October 18, patient was seen at local Hospital to have a revision of her fistula due to issues with dialysis.  This was a 2nd revision within a 6 week period.  She was immediately diagnosed with Covid and kept overnight to have the revision performed next day.  Patient was sedated and revision performed.  The next morning and all day on October 20, it was reported by  nurse that patient seemed confused.  By afternoon, she was incoherent.  Electrodes were hooked  up to her head.  October 21, family was counseled that patient was having constant seizures.   They said they did not know why this was happening.  It was suggested that the covid booster may have been the problem as a friend had just passed away from several strokes within two weeks after his Covid booster.    Patient passed away on Monday, October 24, after family made the difficult decision, based on reports from the doctors that patient may not ever have good brain activity with so many seizures happening.  Patient tried to respond late afternoon on the day she became confused (Thursday, October 20) to me (her sister) over the phone by groaning, and then never responded again.  No response from her between October 20 and October 24 when decision was made late that night to take her off oxygen, etc.
Started with chills, nausea, dry heaves/vomiting early morning Feb 22 which continued into Feb 23rd. Unable to take medications. Death Feb 24th at 2 am.
Woke up in the morning with raised hives covering trunk and extremities.  Took Benadryl as directed on box.  Experienced swelling of eyelids, lips, cheeks on 11/5/12.  Went to physician, given steroids to reduce swelling.
20 hours after administration of vaccine, 7 cm of induration, warmth and erythema at site of Pentacel injection (left upper humerus). Treated with Benadryl, decadron, topicort and cool compress. Resolved after 48 hours.
It was reported that a pt was vaccinated with TD (lot # not recorded) on 2/25/02 during ER visit. Pt returned to ER on 3/3/02 with complains of pain in pectoral muscle and neck region, mild erythema and induration at injection site 6 days post vaccination.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 037I20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (headache). On 27-Mar-2021, HEADACHE (headache) had resolved. Not Provided
Had shot on april 15 at 11 am. In left arm..about 12:00am on the 16 had bad chills,headache, and whole body aches...on the 17 morning had fever of 102 body ached was minimal still had a headache. Morning of 18 felt better still ha e the headache and lots of fatigue...
client had syncope episode after receiving 1st Moderna Covid Vaccine. Vaccinator gave injection. Within seconds client fainted. Another RN attended to client and immediately transferred to anti gravity chair. Lead PHN informed. Upon arrival client was being put in chair. Pale, diaphoretic, awake. Per client felt was going to vomit. PHN handed client nearest trash can. One vomit episode at 1354. Worker brought client water. Per client already feeling much better. PHN asked client if he recalled what occurred. Per client stated "everything went blurry and when I woke up there was many people around me". RN stated client did not get injured, staff able to intervene. At 1357 vitals: blood pressure 130/70, pulse 70. Per client lightheaded improving, mild nausea. Per client only had breakfast, minimal water intake and had been working outdoors all day. Client stated also having history of fainting with needles. 1404 vitals: blood pressure 110/50, pulse 62, oxygen 97%. Per client feeling much better, able to sit straight on gravity chair. PHN advised client to have someone pick him up. Vitals 1409: blood pressure 112/50, pulse 73, oxygen 99%. Per client does not follow up with provider. Client advised to follow up with provider and ER precautions given. 1416 vitals: blood pressure 100/50, pulse 69, oxygen 99%. Per client all symptoms resolved, waiting on ride. Last vitals at 1424: blood pressure 115/50, pulse 65, oxygen 96%. Client able to stand up with no dizziness. Client left facility at 1429 with steady gait.
Drug Allergies: Niacin, Pneumococcal vaccine-rash; Drug Allergies: Niacin, Pneumococcal vaccine-rash; This is a spontaneous report from a contactable nurse.  A 78-year-old male patient received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (manufacturer unknown), via an unspecified route of administration on an unspecified date at single dose for immunisation and nicotinic acid (NIACIN), via an unspecified route of administration from an unspecified date at an unknown dose and frequency for an unspecified indication.  The patient medical history and concomitant medications were not reported.  It was reported on an unspecified date that the patient had drug allergies: niacin, pneumococcal vaccine-rash. The action taken in response to the event for nicotinic acid was unknown. The outcome of the events was unknown.   Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein)  in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of (pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities.  Information on the batch number has been requested.
C/o lightheaded ness, upon assessment pt was cold, clammy, diaphoretic. Paramedics V/S  HR 73, BP 118/69. pt s/s resolved, able to be discharged without s/s distress.
I got little red bump on my body; They were itching and burning; They were itching and burning; Look little flee bites; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Aug2021 09:30 (Lot number: Fc3180) at the age of 43 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: pork" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Product: COVID 19, Brand: Pfizer, Lot number: Fa7485 Lot unknown: False, Administration time: 09:30 AM, Dose number: 1, Vaccine location: Left arm), administration date: 18Jul2021, when the patient was 43 years old, for COVID-19 immunization. The following information was reported: RASH MACULAR (non-serious) with onset 08Aug2021 12:00, outcome "recovered" (2021), described as "I got little red bump on my body"; PRURITUS (non-serious), BURNING SENSATION (non-serious) all with onset 08Aug2021 12:00, outcome "recovered" (2021) and all described as "They were itching and burning"; ARTHROPOD BITE (non-serious) with onset 08Aug2021 12:00, outcome "recovered" (2021), described as "Look little flee bites". Therapeutic measures were not taken as a result of rash macular, pruritus, burning sensation, arthropod bite.  Additional information: Facility type vaccine was pharmacy or drug Store. Patient was not received other vaccine in four weeks. No any other medications in two weeks. Patient was not received treatment for AE. No COVID prior vaccination. Covid was not tested post vaccination. No other medical history.  No follow-up attempts are possible. No further information is expected.
Oxygen level goes below 90; Wheezing; Difficulty breathing / Shortness of breath on exertion; Congested cough; Got very sick; This spontaneous case was received on 12-Oct-2021 from other non-health professional (consumer) via Regulatory authority (reference number: SEQW21-03777) and concerned a 65-year-old, female patient.  The patient's medical history and concomitant medications were not reported.   On an unknown date in 2020, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; dose, route of administration, indication and anatomical location: not reported). The batch number was not reported.  On an unknown date in 2020, exactly two and half weeks after receiving influenza virus vaccine polyvalent, the patient got very sick and experienced difficulty breathing, shortness of breath on exertion, wheezing, congested cough and her oxygen level went below 90.   On an unknown date, the patient recovered from the events of 'oxygen saturation decreased', wheezing, 'dyspnoea' and 'sickness', as all her symptoms cleared up.   On an unknown date, ten months after the onset, the patient recovered from the event of 'productive cough'.  The reporter did not provide causality assessment.  The case is linked to case 202103714 (the same patient).  The reporter assessed all events as serious.  Company comment: A 65-year-old patient was vaccinated with influenza virus vaccine polyvalent. Two and half weeks after receiving influenza virus vaccine polyvalent, the patient got very sick and experienced dyspnoea, shortness of breath on exertion, wheezing, congested cough and her oxygen level went below 90. Due lack of information regarding diagnostic findings, causality is unassessable.; Sender's Comments: A 65-year-old patient was vaccinated with influenza virus vaccine polyvalent. Two and half weeks after receiving influenza virus vaccine polyvalent, the patient got very sick and experienced dyspnoea, shortness of breath on exertion, wheezing, congested cough and her oxygen level went below 90. Due lack of information regarding diagnostic findings, causality is unassessable.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: EN6206), in right arm, on 24Mar2021 as dose 2, single (Lot number: ER8730), in right arm, on 05Nov2021 as dose 3 (booster), single (Lot number: FF2590), in right arm and on 27May2022 as dose 4 (booster), single (Lot number: FM7553) at the age of 50 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "PMLE" (unspecified if ongoing), notes: Other medical history: PMLE; "BRCA2 positive" (unspecified if ongoing), notes: Other medical history: BRCA2 positive. Concomitant medication(s) included: SAXENDA, start date: 09Aug2021; PREDNISONE, start date: 05Sep2022, stop date: 05Sep2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: indication=Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: It was reported that patient had loose stools are very light, champagne-colored - called doctor and she said to stop taking the medication and if my stools remain light over the weekend to get a liver panel done. Patient had no known allergies. It was reported that patient received vaccine. Patient received other medication in 2 weeks. Patient received Paxlovid treatment for COVID 19.
CHILLS; TIRED; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) 103.5 degree F. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced tired. On 25-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 26-MAR-2021, and was recovering from tired, and chills. This report was non-serious.
The patient was given the dose of Hepatitis B vaccine at 4 PM on 10/14/00, approximately 4 hours later he noted a general body rash with itching. The next day (24 hrs later), he went to Owatonna Hospital ER for symptoms of difficulty breathing.
Patient received HPV and Hep A vaccines in office and was waiting in office following injection. Patient began feeling "funny", became pale. C/o throat feeling tight. Patient was given 25 mg BENADRYL p.o. and followed by epinephrine auto-injection of 0.3 mg. EMT squad was called and pt transported to hospital. Observed at Hosp. and released to home.
Patient developed life threatening thromboembolism ( PEs)  which potentially could have been caused by the Janssen vaccine
21Feb91-1030 pm-tonic convulsion /w eye rolling movement for a duration of less than 3 min. (fever 99F). On 22Feb91-0.30 am, tonic convulsion less than 3 min, no fever, to treatment required on both occasions. No call made to MD on call.
Flushing and feeling of heat going up arms, ears. Itching in scalp and soles of feet.  For 2nd shot checked with PCP and got okay to take 25mg tablet of Benadryl 30 minutes before vaccine shot.  He also said to have the site watch me for 45 minutes after shot.  Reaction to first shot diminished on its own after 2 hours.  After this 2nd shot the Benadryl moderated the reaction and it was over in one hour.
Patient reported having pain in arm starting the night of receiving the vaccinations. She reports pain 7/10 with limited range of motion.  Pain is dull at rest and sharp with any kind of movement. Unable to lift arm above head. She tried Tylenol with minimal relief. She also tried home exercises with minimal increase of range of motion. She returned to clinic 10 days post injections for evaluation. She was diagnosed with frozen shoulder related to vaccine injection. She was order a medrol dose pak and a shoulder xray. She will call our office next week with an update on her symptoms.
Information has been received concerning a 23 year old female with latex allergy and no pertinent medical history who on 03-DEC-2008 was vaccinated IM with the first 0.5mL dose of GARDASIL (lot # 66012/0229X). On 04-FEB-2009 was vaccinated IM with the second 0.5 mL dose of GARDASIL (lot # 660612/0229X), and on 20-MAY-2009 was vaccinated IM with the third 0.5 mL dose of GARDASIL (lot # 661766/0652X). On 21-MAY-2009, the patient developed nausea, muscle arm soreness near the injection site, a temperature of 102 degrees F and 2 episodes of vomiting. The patient recovered on 22-MAY-2009. Additional information has been requested.
Pt received Pneumo shot on 10/29/02. Slowly developed redness at injection site, tender also developed fever, lightheaded and syncope for less than minute yesterday (husband witness). Pt was also given flu-shot same day on other arm.